Streptococcus pneumoniae capsular polysaccharide conjugated to protein carrier

Streptococcus pneumoniae capsular polysaccharide conjugated to protein carrier refers to a vaccine antigen in which the polysaccharide component of the bacterial capsule from specific serotypes of *Streptococcus pneumoniae* is chemically linked (conjugated) to an immunogenic protein carrier (such as CRM197, tetanus toxoid, diphtheria toxoid, or others). This chemical linkage converts the otherwise poorly immunogenic polysaccharide into a T-cell-dependent antigen, resulting in robust antibody production and immunological memory, especially important in infants and young children who are unable to respond effectively to plain polysaccharide antigens. Such conjugates are the basis for licensed pneumococcal conjugate vaccines, providing protection against multiple S. pneumoniae serotypes. Importantly, "Streptococcus pneumoniae capsular polysaccharides conjugated to protein carriers" is not a molecular target (e.g., receptor, enzyme, transporter), but an immunogen or vaccine component, so it is not considered a "therapeutic target" in the conventional sense and is not suitable as a canonical drug target entry. Key Notes on Entry Suitability: - This entity is not a therapeutic target, but a vaccine antigen comprised of a diverse set of serotype-specific glycoconjugates. - The phrasing is composite: Each serotype's polysaccharide (e.g., serotype 6B, 19F, etc.) is separately conjugated to a protein, so "Streptococcus pneumoniae capsular polysaccharides conjugated to protein carriers" represents a vaccine technology rather than a unique molecular target. - For structured databases, individual antigens or conjugate pairs should be listed separately per serotype and carrier. The current designation is too broad and not a druggable target as conventionally defined.

Other names

Pneumococcal capsular polysaccharide-protein conjugateStreptococcus pneumoniae polysaccharide-protein conjugatePneumococcal conjugate vaccine component

Induction of specific immune responses against S. pneumoniae capsular polysaccharide antigens via T-cell dependent pathway; Enhancement of immunogenicity of polysaccharide antigens by conjugation to immunogenic protein carrier